Stock-Based Compensation (Details) (USD $)	6 Months Ended				12 Months Ended	6 Months Ended	3 Months Ended		6 Months Ended		3 Months Ended	6 Months Ended
	Jun. 29, 2013	Jun. 30, 2012	Jun. 29, 2013 Performance Shares [Member]	Jun. 29, 2013 Stock Options [Member]	Dec. 29, 2012 Stock Options [Member]	Jun. 29, 2013 Restricted Stock Units (RSUs) [Member]	Jun. 29, 2013 2007 Long-term Equity Incentive Plan [Member]	Jun. 30, 2012 2007 Long-term Equity Incentive Plan [Member]	Jun. 29, 2013 2007 Long-term Equity Incentive Plan [Member]	Jun. 30, 2012 2007 Long-term Equity Incentive Plan [Member]	Jun. 29, 2013 2007 Long-term Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member]	Jun. 29, 2013 2007 Long-term Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested (shares)			0			(352,500)
Forfeited (shares)			0			(1,250)
Stock-based compensation provision	$ 1,977,000	$ 2,993,000					$ 1,000,000	$ 1,400,000	$ 2,000,000	$ 3,000,000
Unrecognized compensation cost related to unvested share-based compensation grants							5,900,000		5,900,000
Weighted average amortization period of unvested share-based compensation grants									1 year 7 months 6 days
Narrative Disclosures [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value											400,000	900,000
Options, Outstanding [Roll Forward]
Options outstanding as of the year ended				2,226,000
Options granted				189,500
Options exercised				0
Options forfeited				(117,500)
Options outstanding as of the year ended				2,298,000	2,226,000
Options Outstanding, Weighted Average Exercise Price [Roll Forward]
Wt avg exercise price outstanding as of the year ended				$ 7.75
Wt avg exercise price granted				$ 2.00
Wt avg exercise price exercised				$ 0.00
Wt avg exercise price forfeited				$ 5.52
Wt avg exercise price outstanding as of the year ended				$ 7.39	$ 7.75
Wt Avg Exercise Price, Contractual Term, Intrinsic Value, Options, Additional Disclosures [Abstract]
Wt avg remain contract term outstanding as of the year ended				2 years 6 months	2 years 8 months 12 days
Intrinsic value outstanding as of the year ended				24,000	0
Intrinsic value exercised as of the year ended				0
Exercisable, options, as of the year ended				1,586,625
Exercisable, wt avg exercise price as of the year ended				$ 8.67
Exercisable, wt avg remaining contractual term as of the year ended				2 years
Exercisable, intrinsic value as of the year ended				$ 0
Weighted Average, Fair Value Assumptions [Abstract]
Weighted average fair value of option grants during the year				$ 1.01
Expected option life in years				4 years 3 months
Risk-free interest rate				0.50%
Expected volatility				65.70%
Expected dividend yield				0.00%
Nonvested, Restricted Shares and RSUs, Number of Shares [Roll Forward]
Unvested as of the year ended (shares)			0			1,074,340
Granted (shares)			730,500			549,500
Unvested as of the year ended (shares)			730,500			1,270,090
Nonvested, Restricted Shares and RSUs, Weighted Average Grant Date Fair Value [Roll Forward]
Unvested as of the year ended (fair value)			$ 0			$ 5.44
Granted (fair value)			$ 2.00			$ 2.00
Vested (fair value)			$ 0			$ 6.29
Forfeited (fair value)			$ 0			$ 5.62
Unvested as of the year ended (fair value)			$ 2.00			$ 2.85